Demarest advised Brenntag on the deal.Brenntag (Holding) B.V. announced the acquisition of 100% of the quotas of the capital stock of Pharmaspecial – Especialidades Químicas e…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
